Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc
Journal website https://www.jocmr.org

Review

Volume 16, Number 4, April 2024, pages 133-137


The Determinants of Eosinophilia in Patients With Severe Asthma

Tables

Table 1. Baseline Characteristics of Studied Population
 
VariableN = 2,646Asthma with eosinophilia (n = 882)Asthma without eosinophilia (n = 1,764)
SD: standard deviation.
Age, years, mean ± SD48 ± 2148 ± 2148 ± 21
Sex, female, n (%)1,562 (59%)514 (58.3)1,048 (59.4)
White, n (%)1,490 (56%)480 (54.4)1,010 (57.3)
Black, n (%)568 (21%)192 (21.8)376 (21.3)
Hispanic, n (%)404 (15%)139 (15.8)265 (15.0)
Current smokers277 (10%)101 (11.5)176 (10.0)
Obesity504 (19%)182 (20.6)322 (18.3)

 

Table 2. Measured Outcomes
 
OutcomesAsthma with eosinophilia (n = 882)Asthma without eosinophilia (n = 1,764)P value
GERD: gastroesophageal reflux disease; IQR: interquartile range; NSAIDs: non-steroidal anti-inflammatory drugs.
Chronic steroid use161 (18.3)168 (9.5)< 0.001
Status asthmaticus92 (10.4)131 (7.4)0.009
Family history of asthma39 (4.4)42 (2.4)0.004
Allergies183 (20.7)304 (17.2)0.028
Allergy to NSAIDs22 (2.5)28 (1.6)0.106
Nasal polyps17 (1.9)1 (0.1)< 0.001
Allergic rhinitis35 (4.0)22 (1.2)< 0.001
Allergic dermatitis33 (3.7)7 (0.4)< 0.001
Mechanical ventilation55 (6.2)60 (3.4)< 0.001
Oxygen supplementation114 (12.9)108 (6.1)< 0.001
GERD206 (23.4)368 (20.9)0.142
In-hospital mortality, n (%)7 (0.8)21 (1.2)0.347
Hospital length of stay, days, median (IQR)3 (2 - 6)3 (2 - 5)< 0.001